Literature DB >> 34303065

Generation of Tumor-activated T cells Using Electroporation.

Nastaran Alinezhadbalalami1, Philip M Graybill2, Khan Mohammad Imran3, Scott S Verbridge4, Irving C Allen5, Rafael V Davalos6.   

Abstract

Expansion of cytotoxic T lymphocytes (CTLs) is a crucial step in almost all cancer immunotherapeutic methods. Current techniques for expansion of tumor-reactive CTLs present major limitations. This study introduces a novel method to effectively produce and expand tumor-activated CTLs using high-voltage pulsed electric fields. We hypothesize that utilizing high-voltage pulsed electric fields may be an ideal method to activate and expand CTLs due to their non-thermal celldeath mechanism. Tumor cells were subjected to high-frequency irreversible electroporation (HFIRE) with various electric field magnitudes (1250, 2500 V/cm) and pulse widths (1, 5, and 10 µs), or irreversible electroporation (IRE) at 1250 V/cm. The treated tumor cells were subsequently cocultured with CD4+ and CD8+ T cells along with antigen-presenting cells. We show that tumor-activated CTLs can be produced and expanded when exposed to treated tumor cells. Our results suggest that CTLs are more effectively expanded when pulsed with HFIRE conditions that induce significant cell death (longer pulse widths and higher voltages). Activated CD8+ T cells demonstrate cytotoxicity to untreated tumor cells suggesting effector function of the activated CTLs. The activated CTLs produced with our technique could be used for clinical applications with the goal of targeting and eliminating the tumor.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-tumor immunity; Antigen presentation; Cytotoxic T cell; High frequency irreversible electroporation; Irreversible electroporation; T cell Activation

Mesh:

Year:  2021        PMID: 34303065      PMCID: PMC8504467          DOI: 10.1016/j.bioelechem.2021.107886

Source DB:  PubMed          Journal:  Bioelectrochemistry        ISSN: 1567-5394            Impact factor:   5.373


  53 in total

1.  Intracellular effect of ultrashort electrical pulses.

Authors:  K H Schoenbach; S J Beebe; E S Buescher
Journal:  Bioelectromagnetics       Date:  2001-09       Impact factor: 2.010

2.  Role of direct effects of IFN-gamma on T cells in the regulation of CD8 T cell homeostasis.

Authors:  Kavita Tewari; Yumi Nakayama; M Suresh
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

3.  Engineering T cell response to cancer antigens by choice of focal therapeutic conditions.

Authors:  Qi Shao; Stephen O'Flanagan; Tiffany Lam; Priyatanu Roy; Francisco Pelaez; Brandon J Burbach; Samira M Azarin; Yoji Shimizu; John C Bischof
Journal:  Int J Hyperthermia       Date:  2019-01-24       Impact factor: 3.914

Review 4.  A brief overview of electroporation pulse strength-duration space: a region where additional intracellular effects are expected.

Authors:  James C Weaver; Kyle C Smith; Axel T Esser; Reuben S Son; T R Gowrishankar
Journal:  Bioelectrochemistry       Date:  2012-03-14       Impact factor: 5.373

5.  The feasibility of using dielectrophoresis for isolation of glioblastoma subpopulations with increased stemness.

Authors:  Nastaran Alinezhadbalalami; Temple A Douglas; Nikita Balani; Scott S Verbridge; Rafael V Davalos
Journal:  Electrophoresis       Date:  2019-06-06       Impact factor: 3.535

6.  Phenotype and function of T cells infiltrating visceral metastases from gastrointestinal cancers and melanoma: implications for adoptive cell transfer therapy.

Authors:  Simon Turcotte; Alena Gros; Katherine Hogan; Eric Tran; Christian S Hinrichs; John R Wunderlich; Mark E Dudley; Steven A Rosenberg
Journal:  J Immunol       Date:  2013-07-31       Impact factor: 5.422

Review 7.  Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy.

Authors:  Hester J Scheffer; Karin Nielsen; Marcus C de Jong; Aukje A J M van Tilborg; Jenny M Vieveen; Arthur R A Bouwman; Sybren Meijer; Cornelis van Kuijk; Petrousjka M P van den Tol; Martijn R Meijerink
Journal:  J Vasc Interv Radiol       Date:  2014-03-18       Impact factor: 3.464

8.  High-Frequency Irreversible Electroporation for Treatment of Primary Liver Cancer: A Proof-of-Principle Study in Canine Hepatocellular Carcinoma.

Authors:  Brittanie R Partridge; Timothy J O'Brien; Melvin F Lorenzo; Sheryl L Coutermarsh-Ott; Sabrina L Barry; Krystina Stadler; Noelle Muro; Mitchell Meyerhoeffer; Irving C Allen; Rafael V Davalos; Nikolaos G Dervisis
Journal:  J Vasc Interv Radiol       Date:  2020-01-16       Impact factor: 3.464

Review 9.  Tumor-infiltrating lymphocytes in the immunotherapy era.

Authors:  Sterre T Paijens; Annegé Vledder; Marco de Bruyn; Hans W Nijman
Journal:  Cell Mol Immunol       Date:  2020-11-02       Impact factor: 11.530

10.  Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice.

Authors:  Robert E Neal; John H Rossmeisl; John L Robertson; Christopher B Arena; Erica M Davis; Ravi N Singh; Jonathan Stallings; Rafael V Davalos
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

View more
  1 in total

Review 1.  Exploration of Novel Pathways Underlying Irreversible Electroporation Induced Anti-Tumor Immunity in Pancreatic Cancer.

Authors:  Khan Mohammad Imran; Margaret A Nagai-Singer; Rebecca M Brock; Nastaran Alinezhadbalalami; Rafael V Davalos; Irving Coy Allen
Journal:  Front Oncol       Date:  2022-03-18       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.